Claims
- 1. A compound of the formula ##STR7## or a pharmaceutically acceptable acid addition salt thereof, wherein R.sup.1 and R.sup.2 are different and one is alkyl of 1 to 6 carbon atoms and the other is isopropyl, and A and B together represent a covalent bond.
- 2. The compound according to claim 1, wherein said alkyl of 1 to 6 carbon atoms is ethyl.
- 3. The compound according to claim 1, which is a pharmaceutically acceptable acid addition salt.
- 4. The compound according to claim 2, wherein said salt is a hydrochloride.
- 5. 6,7-diethoxy-1-(3',4'-diisopropoxybenzyl)-3,4-dihydroisoquinoline, or its hydrochloride.
- 6. 1-(3',4'-diethoxybenzyl)-6,7-diisopropoxy-3,4-dihydroisoquinoline, or its hydrochloride or ascorbate.
- 7. A pharmaceutical composition for the treatment of peripheral vascular disease which comprises from 50 to 500 mg of a compound as claimed in claim 1 together with a pharmaceutically acceptable carrier.
CROSS-REFERENCE
This is a continuation of Ser. No. 196,322 filed Oct. 14, 1980, abandoned which is a continuation of Ser. No. 898,145 filed Apr. 20, 1978, abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
2928769 |
Shepard |
Dec 1955 |
|
3978063 |
Kishimoto et al. |
Aug 1976 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
1417542 |
Oct 1975 |
GBX |
Continuations (2)
|
Number |
Date |
Country |
Parent |
196322 |
Oct 1980 |
|
Parent |
898145 |
Apr 1978 |
|